论文部分内容阅读
目的:探讨盐酸氨溴索颗粒联合阿奇霉素治疗小儿支原体肺炎的临床疗效。方法:将2016年1月1日~6月30日期间于我院就诊的64例支原体肺炎患儿分为两组,对照组32例,仅通过静滴阿奇霉素治疗;观察组32例,应用盐酸氨溴索颗粒联合静滴阿奇霉素治疗,比较两组患儿的临床疗效与症状消失时间。结果:观察组治疗有效率93.7%(30/32),对照组治疗有效率78.1%(25/32)(P<0.05);观察组咳嗽、发热、X线炎症、肺部体征等临床症状的消失时间均短于对照组(P<0.05)。结论:在支原体肺炎患儿的临床治疗中,采用盐酸氨溴索颗粒与静滴阿奇霉素联合治疗方案,可迅速缓解患儿症状,安全可靠,临床效果显著,有助于促进患儿康复。
Objective: To investigate the clinical efficacy of ambroxol hydrochloride combined with azithromycin in treating children with mycoplasma pneumonia. Methods: Sixty-four patients with mycoplasma pneumonia who were treated in our hospital from January 1 to June 30, 2016 were divided into two groups. The control group, 32 cases, were treated with intravenous azithromycin only. In the observation group, 32 cases were treated with hydrochloric acid Ambroxol granule combined with intravenous infusion of azithromycin treatment, the clinical efficacy and symptoms disappear time in both groups. Results: The effective rate of the observation group was 93.7% (30/32), while that of the control group was 78.1% (25/32) (P <0.05). The clinical symptoms such as cough, fever, X-ray inflammation and lung signs in the observation group Disappear time were shorter than the control group (P <0.05). Conclusion: In the clinical treatment of children with mycoplasma pneumonia, the combination of ambroxol hydrochloride granules and intravenous azithromycin can relieve the symptoms of children with safety and reliability. The clinical effect is significant and helps to promote the rehabilitation of children.